Suncorp share price edges higher after announcing its new operating model

The Suncorp Group Ltd (ASX:SUN) share price is edging higher on Wednesday after announcing a new operating model. Here's what you need to know…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Suncorp Group Ltd (ASX: SUN) share price is edging higher on Wednesday after announcing a new operating model and leadership structure.

At the time of writing the insurance and banking giant's shares are up 0.25% to $9.25.

What did Suncorp announce?

Suncorp has announced a new operating model and leadership structure which it believes will drive further improvements in its core insurance and banking businesses. It also expects the initiatives to accelerate its digital and data driven transformation. The latter of which has increased in importance following the pandemic.

Suncorp's CEO Steve Johnston explained: "COVID-19 has resulted in changes such as the faster adoption of digital channels by customers and new, more innovative and agile internal ways of working. It has changed our perspective on what is possible."

"We now need to seize this opportunity to speed up the execution of our priorities so we can continue to deliver for our people and customers, while growing returns and creating better outcomes for our shareholders," he added.

What changes are being made?

According to the release, the key operating model changes are as follows:

  • Accountability for the performance of Insurance (Australia) to be assumed by two executives. One will be focused on underwriting, distribution, brands, marketing, product design, and innovation. The other will be responsible for all aspects of claims management and operations.
  • Combining a number of Insurance (Australia) and company functions to create a more streamlined and efficient organisation.
  • Greater end-to-end operational accountability within Banking & Wealth and Suncorp New Zealand to drive improved performance.
  • Aligning Group Strategy and Technology to fast-track digital and automation capabilities and opportunities.

FY 2021 Reinsurance Program.

Suncorp also advised that it has finalised its catastrophe reinsurance program for FY 2021.

The structure of the program will remain largely consistent with prior years. However, the maximum loss limit is lower than FY 2020 as a result of reduced Commercial Insurance exposures in Australia and increased building coverage through the Earthquake Commission in New Zealand.

Suncorp's maximum event retention remains at $250 million. The main catastrophe program includes one prepaid reinstatement which covers losses up to $6.5 billion for a second event and two further prepaid statements at the lower layer. These will cover losses up to $500 million for the third and fourth events.

In addition to this, Suncorp has purchased dropdown aggregate protection and Aggregate Excess of Loss (AXL) cover.

Finally, management also provided an update on its COVID-19 impact. The impact on its profit and loss is expected to be broadly neutral in FY 2020. Though, this is excluding investment market movements and Bank impairment losses.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

Woman calculating dividends on calculator and working on a laptop.
Share Market News

Charter Hall Group declares interim distribution for 1H FY26

Charter Hall Group declares a 24.83-cent half-year distribution for the six months to 31 December 2025, with most of it…

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Andean Silver, Boss Energy, Chalice Mining, and Rio Tinto shares are falling today

These shares are starting the week in the red. But why?

Read more »

A man leaps from a stack of gold coins to the next, each one higher than the last.
Broker Notes

Up 300% this year, 3 reasons to buy this ASX All Ords gold stock today

A leading broker sees further ‘clear upside’ potential for this rocketing ASX gold stock.

Read more »

asx silver shares represented by silver bull statue next to silver bear statue
Share Fallers

Up 118% in 2025, why is this All Ords ASX silver share crashing on Monday?

Investors are punishing this outperforming ASX silver share today. But why?

Read more »

A couple sit in their home looking at a phone screen as if discussing a financial matter.
Share Market News

APA Group gains $1bn extra funding capacity after S&P credit rating change

S&P’s credit rating change gives APA Group over $1 billion in extra capacity to fund new energy infrastructure projects.

Read more »

two men in suits shake hands at the top of a shined wood boardroom table.
Share Market News

DigiCo Infrastructure REIT appoints new CEO and sets strategic growth path

DigiCo Infrastructure REIT has appointed Michael Juniper as CEO, with a focus on powering the next phase of digital infrastructure…

Read more »

Four smiling young medics with arms crossed stand outside a hospital.
Share Market News

Telix Pharmaceuticals updates investors as first patient is dosed in Phase 3 prostate cancer trial

Telix Pharmaceuticals updates on its prostate cancer Phase 3 trial, dosing the first Part 2 patient and outlining regulatory plans.

Read more »